Sanyal Sanyal and colleagues conducted a randomized, double-blind, phase 2 study of retatrutide, a novel triple agonist of GIP, GLP-1 and glucagon receptors, vs
People with heart disease should be cautious, as very high doses may raise Trimethylamine-N-oxide (TMAO), a compound linked to cardiovascular risk
Some patients find that taking their injection in the evening and sleeping through the peak nausea window (hours 24) makes the experience much more tolerable than daytime dosing
Increased G6pc expression in Insr P1195L/ +/HFD liver could therefore result from impaired repression by insulin in liver and/or be secondary to increased glycerol influx to liver
Anecdotally it is being used to reduce gut inflammation and heal leaky gut, and to heal muscle, tendon or ligament injuries
Previous studies have suggested that deficiency in GLP-1 secretion partly contribute to the diminished incretin effect typically observed among Caucasians with T2D ( 2 Materials and methods 2.1 Study participants This was a prospective study conducted over a 12-week period